BMP 2; Bone formation; Bone morphogenetic proteins; Osteoinduction
Indexed keywords
BMP2 PROTEIN, HUMAN;
BMP2 PROTEIN, MOUSE;
BMP2 PROTEIN, RAT;
BONE MORPHOGENETIC PROTEIN;
BONE MORPHOGENETIC PROTEIN 2;
COLLAGEN;
DRUG CARRIER;
PROTEIN;
RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2;
RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2;
RECOMBINANT PROTEIN;
TRANSFORMING GROWTH FACTOR BETA;
ABDOMINAL WALL MUSCULATURE;
ANIMAL;
ARTICLE;
BONE DEVELOPMENT;
CARTILAGE;
CARTILAGE CELL;
CELL DIFFERENTIATION;
CULTURE TECHNIQUE;
DOSE RESPONSE;
DRUG EFFECT;
ESCHERICHIA COLI;
GENE EXPRESSION REGULATION;
GENETICS;
HETEROTOPIC OSSIFICATION;
HUMAN;
INSTITUTE FOR CANCER RESEARCH MOUSE;
MESODERM;
METABOLISM;
MOUSE;
PATHOLOGY;
RAT;
SKELETAL MUSCLE;
SPRAGUE DAWLEY RAT;
Identification of transforming growth factor β family members present in bone-inductive protein purified from bovine bone
CELESTE JA, IANNAZZI JA, TAYLOR RC, et al. Identification of transforming growth factor β family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA 1990: 87: 9843-7
The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2
KATAGIRI T, YAMAGUCHI A, IKEDA T, et al. The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem Biophys Res Commun 1990: 172: 295-9
Cell differentiation in response to partially purified osteosarcoma-derived bone morphogenetic protein in vivo and in vitro
KÜBLER N, URIST MR. Cell differentiation in response to partially purified osteosarcoma-derived bone morphogenetic protein in vivo and in vitro. Clin Orthop 1993: 292: 321-8.
Igg monoclonal antibodies that inhibit osteoinductivity of human bone matrix-derived proteins (hBMP/NCP)
KÜBLER N, REUTHER J, KIRCHNER T, et al. IgG monoclonal antibodies that inhibit osteoinductivity of human bone matrix-derived proteins (hBMP/NCP). Int J Oral Maxillofac Surg 1994: 23: 420-2.
Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity
RUPPERT R, HOFFMANN E, SEBALD W. Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. Eur J Biochem 1996: 237: 295-302.
Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-beta superfamily
SAMPATH TK, COUGHLIN JE, WHETSTONE RM, et al. Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-beta superfamily. J Biol Chem 1990: 265: 13198-205.
Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro
SAMPATH TK, MALIAKAL JC, HAUSCHKA PV, et al. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 1992: 267: 20352-62.
Gene cloning and expression of a bone morphogenetic protein derived from a murine osteosarcoma
TAKAOKA K, YOSHIKAWA H, HASIMOTO J. et al. Gene cloning and expression of a bone morphogenetic protein derived from a murine osteosarcoma. Clin Orthop 1993: 294: 344-52.
Recombinant human bone morphogenetic protein induces bone formation
WANG EA, ROSEN V, D'ALESSANDRO JS, et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 1990: 87: 2220-4.
